التفاصيل البيبلوغرافية
| العنوان: |
Evaluation of methods for red marrow dosimetry based on patients undergoing radioimmunotherapy. |
| المؤلفون: |
Hindorf, Cecilia, Lindén, Ola, Tennvall, Jan, Wingårdh, Karin, Strand, Sven-Erik |
| المصدر: |
Acta Oncologica; Sep2005, Vol. 44 Issue 6, p579-588, 10p, 2 Black and White Photographs, 3 Diagrams, 7 Charts, 1 Graph |
| مصطلحات موضوعية: |
BONE marrow, DRUG dosage, RADIOIMMUNOTHERAPY, IMMUNOTHERAPY, HEMATOPOIETIC system, IMMUNE system, RADIOTHERAPY |
| مستخلص: |
Red marrow dosimetry is essential during radioimmunotherapy and a reliable method is essential in order to find a measure correlated to the toxic effect observed. The aim of this study was to calculate the absorbed dose to red marrow with different methods for the same patients and to compare the results. Patients diagnosed with B-cell lymphoma were treated with 131 I-labelled monoclonal antibodies (LL2, anti-CD22). Blood samples were collected, scintillation camera images were taken and single probe measurements were carried out at different points in time after administration of the radiopharmaceutical. The absorbed dose to red marrow per unit activity administered was calculated using four varieties of the blood method and from activity quantification in the sacrum in the scintillation camera images. The absorbed dose to the total body per unit activity, sometimes used as a measure for determining the toxic effect in red marrow, was calculated from both the scintillation camera images and the single probe measurements. The results from the different methods of calculating the absorbed dose for the same patient and treatment were compared. The ratio of the maximum and the minimum absorbed dose to red marrow calculated using the four variations of the blood method and the sacrum imaging method for one and the same patient varied between 1.8 and 2.8. The correlation coefficients for all the possible combinations of the dosimetry methods, including total body measurements, varied from 0.51 to 0.99. The results show that the variability of the absorbed dose to the bone marrow is dependent on both method and patient. [ABSTRACT FROM AUTHOR] |
|
Copyright of Acta Oncologica is the property of Medical Journals Sweden AB and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
PDF full text from Publisher